Tony Lange

The state's 45,000-plus medical cannabis patients could receive dispensary products through federal or private mail carriers under the proposed rule change.

The government's final brief for the cannabis rescheduling hearing focuses on currently accepted medical use, a scientific and medical analysis, and the opposition's ‘so-called experts.'

A bipartisan quartet of lawmakers sent a letter to Trump and three cabinet members, asking for clarity on the federal policy for medical cannabis.

A majority of registered voters plan to reject a November ballot question that would backtrack the state's adult-use legalization laws, according to a new poll.

The DEA's administrative law judge said the fully corrected transcript for the cannabis rescheduling hearing will be made public no later than Aug. 26.

John James, a U.S. congressman running on the state's Republican ticket for governor, outlined his cannabis reform policies.

State licensees are seeking injunctive relief over New Mexico's planned rollout of a replacement seed-to-sale system they say is not proven.

With the fully corrected transcripts now part of the public record, the judge who oversaw the hearing's proceedings now must make a recommendation.

The Drug Enforcement Administration tried to discredit nearly all opposing witnesses who testified during the rescheduling hearing in its post-hearing brief.

Some legal experts believe a pharmacologist's testimony on currently accepted medical use could be the most damning for the Schedule III proposal.